Showing 6501-6510 of 8649 results for "".
- Nicox Announces Research Collaboration on Novel Ophthalmic Therapeutics with Ironwood Pharmaceuticalshttps://modernod.com/news/nicox-announces-research-collaboration-on-novel-ophthalmic-therapeutics-with-ironwood-pharmaceuticals/2480117/Nicox SA announced its entry into a research collaboration with Ironwood Pharmaceuticals focused on combining Ironwood’s expertise in soluble guanylate cyclase (sGC) and Nicox’s proprietary nitric oxide (NO)-donating research platform to generate novel compounds in order to identify potential new
- Tobii and Lumus Bring Eye Tracking Technology to Augmented Reality Eyewearhttps://modernod.com/news/tobii-and-lumus-bring-eye-tracking-technology-to-augmented-reality-eyewear/2480121/At the Augmented World Expo (AWE) this week, Tobii announced that it is working with Lumus, a provider of transparent displays for augmented reality (AR), to incorporate eye tracking technology as part of the Lumus DK50 AR development kit.
- Automeyes Optical Solutions Receives Patent for its Signature Measurement Technology Benefiting ECPhttps://modernod.com/news/automeyes-optical-solutions-receives-patent-for-its-signature-measurement-technology-benefiting-ecp/2480123/Automeyes Optical Solutions has officially received the patent for the technology behind Automeyes, which was approved by the U.S. Patent Office in February of 2018. Automeyes Founder and creator, Kurt Gardner, was able to prove the methodology was unique and sound enough to receive patent protec
- Keck Medicine of USC to Open New Ambulatory Clinic in Southern California’s San Gabriel Valleyhttps://modernod.com/news/keck-medicine-of-usc-to-open-new-ambulatory-clinic-in-southern-californias-san-gabriel-valley/2480124/Keck Medicine of USC is expanding its network of ambulatory clinics with a new location in Southern California’s San Gabriel Valley. Located at 125 W. Huntington Drive in <
- Caution Needed With Artificial Intelligence in Medicine, Experts Warnhttps://modernod.com/news/caution-needed-with-artificial-intelligence-in-medicine-experts-warn/2480125/Current hype surrounding machine learning and artificial intelligence (AI) in medicine is enormous, with seemingly daily headlines declaring that some new model will change how a disease is diagnosed or treated. Experts are more cautious, though, with several speakers at the recent
- FDA Approves First Artificial Irishttps://modernod.com/news/fda-approves-first-artificial-iris/2480126/The FDA approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris is completely missing or damaged. “Patients with iris defects may experience severe vision problems, as well as dissatisfaction with the appear
- NTC to Strengthen Its Ophthalmology Portfolio Through the Acquisition of Ocular Antibiotic Productshttps://modernod.com/news/ntc-to-strengthen-its-ophthalmology-portfolio-through-the-acquisition-of-ocular-antibiotic-products/2480127/The Italian pharmaceutical company NTC announced the acquisition of some Novartis ocular antibiotic products, including broad spectrum antibiotic therapies to treat eye diseases. Countries covered under the agreement include Spain, Portug
- Clearside Biomedical Announces Topline Results from Phase 2 Clinical Trial of DME Combination Drughttps://modernod.com/news/clearside-biomedical-announces-positive-topline-results-from-phase-2-clinical-trial-of-dme-combination-drug/2480130/Clearside Biomedical announced positive topline results from its phase 2 clinical trial evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept) in patients with diabetic macular edema (DME) over a 6-month evaluation period, according to a company news release.</
- Study Examines ImprimisRx’s Dropless Steroid and Antibiotic Intravitreal Injectionhttps://modernod.com/news/study-examines-imprimisrxs-dropless-steroid-and-antibiotic-intravitreal-injection/2480133/Imprimis Pharmaceuticals’ ophthalmology compounding division, ImprimisRx, has announced the findings from a study published in the Journal of Cataract and Refractive Surgery that followed 483 eyes with glaucoma that were undergoing cataract surgery with concomitant trabecular micro
- Aggressive Steroid Therapy Improves Visual Outcomes in Vogt-Koyanagi-Harada Diseasehttps://modernod.com/news/aggressive-steroid-therapy-improves-visual-outcomes-in-vogt-koyanagi-harada-disease/2480135/Aggressive treatment beginning with pulsed intravenous corticosteroids appears to improve visual outcomes of new-onset acute Vogt-Koyanagi-Harada (VKH) disease, researchers from Japan report, according to a report in Medscape. VKH d